Receptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow for Difficult Therapeutic Targets

Summary

Receptor.AI and Sethera announced a collaboration to combine Receptor.AI's computational platform with Sethera's polymacrocyclic peptide chemistry and screening capabilities for therapeutic target discovery. Each company will retain its proprietary platform technologies.